
Novedades en investigacion marzo 2006 (6)
Novedades en investigacion marzo 2006
Fuente y mas informacion
The Myeloma Minute - March 29, 2006
http://readtheminute.myeloma.org/
Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies
http://www.bloodjournal.org/cgi/content/abstract/107/7/2633?etoc
Bart Barlogie*, Guido Tricot*, Erik Rasmussen, Elias Anaissie, Frits van Rhee, Maurizio Zangari, Athanasios Fassas, Klaus Hollmig, Mauricio Pineda-Roman, John Shaughnessy, Joshua Epstein, and John Crowley*
Blood 2006;107 2633-2638
Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin
http://www.bloodjournal.org/cgi/content/abstract/107/7/2895?etoc
Martin S. Zand, Thuong Vo, Tina Pellegrin, Raymond Felgar, Jane L. Liesveld, Jainulabdeen J. Ifthikharuddin, Camille N. Abboud, Ignacio Sanz, and Jennifer Huggins
Blood 2006;107 2895-2903
Gentium Receives First IRB Approval to Begin U.S. Phase III Trial with Defibrotide to Treat Veno-Occlusive Disease with Multiple-Organ Failure
http://www.pharmalive.com/News/inde...9&categoryid=21
The U.S. Food and Drug Administration (FDA) has granted Defibrotide Orphan Drug Status and Fast Track designation for the treatment of Severe VOD, a complication of stem cell transplant. (from PharmaLive)
Lymphoma Drug Effective Against Chronic GVHD
http://www.cancerpage.com/news/article.asp?id=9531
More research points to the benefit of using the drug rituximab to combat chronic graft-versus-host disease (GVHD) in cancer patients who get allogenic bone marrow transplants( BMT).(from CancerPage)
____________
Guia de Uso -
http://www.mieloma.com/v2/uso-del-foro-vf27.html
Ser feliz no significa que todo sea perfecto, quiere decir que has decidido seguir adelante pese a las dificultades.